Sleep disorders and changes in melatonin concentrations in pregnant women with preeclampsia

Home/2023, Vol. 11, No. 2/Sleep disorders and changes in melatonin concentrations in pregnant women with preeclampsia

Cell and Organ Transplantology. 2023; 11(2):130-135.
DOI: 10.22494/cot.v11i2.158

Sleep disorders and changes in melatonin concentrations in pregnant women with preeclampsia

Savka R., Berbets A.

  • Bukovinian State Medical University, Chernivtsi, Ukraine

Abstract

Melatonin plays a significant role in the development of normal pregnancy, in particular, it contributes to the successful implantation of the fertilized egg, affects the act of childbirth, is actively produced by the trophoblast and placenta, reduces oxidative stress, in particular, with preeclampsia. In addition, melatonin is one of the essential hormones in the protection of the endothelium and stem cells from the oxidative stress.
Objective – to study the mechanisms of development, terms of manifestation, and types of sleep disorders, as well as changes in the concentrations of melatonin in the blood of pregnant women with preeclampsia.
Methods. 50 pregnant women at a mean age of 29.1 ± 3.4 years who had preeclampsia in the 3rd pregnancy trimester were examined (experimental group). All women in the research group had a gestation term of 30-32 weeks of pregnancy. The control group consisted of 33 women with a mean age of 31.2 ± 6.6 years who had an uncomplicated pregnancy. The presence of sleep disorders was established using a questionnaire: pregnant women were asked about the term of pregnancy in which complaints of sleep disorders appeared, the nature of sleep disorders, the frequency of episodes of sleep disorders (how many times a week such a condition was noted), etc. The concentration of melatonin in the venous blood of the examined pregnant women was determined by ELISA. Blood was taken at 9:00 a.m., on an empty stomach, and all patients were analyzed at the same time of a day.
Results. The study showed that sleep disorders in pregnant women with pre-eclampsia, which complicates the pregnancy in the 3rd trimester, occurred earlier, compared to women with an uncomplicated pregnancy: pregnant women with pre-eclampsia were more likely to notice worsening of sleep, starting from 22-30 weeks of pregnancy (in 26.0 % of cases), while in pregnant women with a physiological pregnancy, similar complaints appeared mainly after 30 weeks. In the third trimester of pregnancy women with preeclampsia were more likely to wake up 2 or more times per night (in 68.0 % of cases) compared to controls (in 23.3 % of cases, p < 0.001) and 3 or more times per night per week (in 54.0 % of cases, in controls – in 16.7 % of cases, p < 0.001), which may be a consequence of a disorder of the function of the pineal gland. Women with preeclampsia were more likely (56.0 % vs. 13.3 % in the control group, p < 0.01) to use gadgets (electronic devices, mainly smartphones) for more than 2 hours after 9:00 p.m., which also negatively affects the function of the pineal gland. In pregnant women whose pregnancy was complicated by preeclampsia in the 3rd trimester, a significant (1.8-fold) decrease in the level of melatonin in venous blood taken at 9 a.m. was observed, compared to women with an uncomplicated pregnancy (p = 0.029).
Conclusion. Sleep disorders in pregnant women with preeclampsia occur earlier and are more expressed compared to women with an uncomplicated pregnancy. The appearance of complaints of insomnia in the second trimester of pregnancy, in our opinion, can be considered a diagnostic sign of pineal gland dysfunction in preeclampsia. A decrease in the level of melatonin in pregnant women with preeclampsia, established against the background of minimal daily activity of the pineal gland (at 9 a.m.), indicates a decrease in the melatonin-producing function of the placenta which might have an impact on the condition of stem cells of fetus and placenta.

Key words: pregnancy; placenta; preeclampsia; pineal gland; melatonin; sleep disorders


Full Text PDF

1. Grishchenko VI. Rol’ epifiza v fiziologii i patologii zhenskoy polovoy sistemy [Role of a pineal gland in physiology and pathology of woman’s reproductive system] Khar’kiv: Vyshcha shkola. 1979;248 s. [in Russian].
2. Shimada M, Seki H, Samejima M, Hayase M, Shirai F. Salivary melatonin levels and sleep-wake rhythms in pregnant women with hypertensive and glucose metabolic disorders: A prospective analysis. BioSci Trends. 2016.
https://doi.org/10.5582/bst.2015.01123
PMid:26853813
3. Soliman A, Lacasse A, Lanoix D, Sagrillo-Fagundes L, Boulard V, Vaillancourt C. Placental melatonin system is present throughout pregnancy and regulates villous trophoblast differentiation. J Pineal Res. 2015; 59(1):38-46.
https://doi.org/10.1111/jpi.12236
PMid:25833399
4. Takayama H, Nakamura Y, Tamura H. Pineal gland (melatonin) Affects the parturition time but not luteal function and fetal growth, in pregnant rats. Endocr J. 2003; 50(1):37-43.
https://doi.org/10.1507/endocrj.50.37
PMid:12733707
5. Teixeira AA, Simoes MJ, Wanderley Teixeira V, Soares JJr. Evaluation of the implantation in pinealectomized and/or submitted to the constant illumination rats. Int J Morphol. 2004; 22(3):189-194.
https://doi.org/10.4067/S0717-95022004000300003
6. Richter HG, Hansell JA, Raut Sh, Giussani DA. Melatonin improves placental efficiency and birth weight and increases the placental expression of antioxidant enzymes in undernourished pregnancy. J Pineal Res. 2009; 46:357-364.
https://doi.org/10.1111/j.1600-079X.2009.00671.x
PMid:19552758
7. Reiter RJ, Dun Xian Tan, Korkmaz A, Rosales-Corral SA. Melatonin and stable circadian rhythms optimize maternal, placental and fetal physiology. Hum Reprod Update. 2013; 20(2):293-307.
https://doi.org/10.1093/humupd/dmt054
PMid:24132226
8. Marseglia L, D’Angelo G, Manti S, Reiter RJ, Gitto E. Potential Utility of melatonin in preeclampsia, intrauterine fetal growth retardation, and perinatal asphyxia. Reprod Sci. 2016; 23(8):970-977.
https://doi.org/10.1177/1933719115612132
PMid:26566856
9. Rana S, Lemoine E, Granger JP, Karumanchi SA. Preeclampsia: Pathophysiology, Challenges, and Perspectives [published correction appears in Circ Res. 2020 Jan 3;126(1):e8]. Circ Res. 2019; 124(7):1094-1112.
https://doi.org/10.1161/CIRCRESAHA.118.313276
PMid:30920918
10. Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia-Pathophysiology and Clinical Presentations: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 76(14):1690-1702.
https://doi.org/10.1016/j.jacc.2020.08.014
PMid:33004135
11. Roberts JM, Rich-Edwards JW, McElrath TF, Garmire L, Myatt L; Global Pregnancy Collaboration. Subtypes of Preeclampsia: Recognition and Determining Clinical Usefulness. Hypertension. 2021; 77(5):1430-1441.
https://doi.org/10.1161/HYPERTENSIONAHA.120.14781
PMid:33775113 PMCid:PMC8103569
12. Pant V, Yadav BK, Sharma J. A cross sectional study to assess the sFlt-1: PlGF ratio in pregnant women with and without preeclampsia. BMC Pregnancy Childbirth [Internet]. 2019; 19(1):266.
https://doi.org/10.1186/s12884-019-2399-z
PMid:31345176 PMCid:PMC6659302
13. Chuffa LGA, Lupi LA, Cucielo MS, Silveira HS, Reiter RJ, Seiva FRF. Melatonin Promotes Uterine and Placental Health: Potential Molecular Mechanisms. Int J Mol Sci. 2020.
https://doi.org/10.3390/ijms21010300
PMid:31906255 PMCid:PMC6982088
14. Cipolla-Neto J. Melatonin as a hormone: new physiological and clinical insights. Endocr Rev. 2018;39(6):990-1028.
https://doi.org/10.1210/er.2018-00084
PMid:30215696
15. Kusuma GD, Georgiou HM, Perkins AV, Abumaree MH, Brennecke SP, Kalionis B. Mesenchymal Stem/Stromal Cells and Their Role in Oxidative Stress Associated with Preeclampsia. Yale J Biol Med. 2022; 95(1):115-127. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961706/
16. Ministry of Health of Ukraine. Unified clinical protocol for primary, secondary (specialized) and tertiary (highly specialized) medical care “Hypertensive disorders during pregnancy, childbirth and the postpartum period”. Approved by the Order of the Ministry of Health of Ukraine of January 24, 2022, #151. Kyiv: Ministry of Health of Ukraine; 2022. 56 p. [In Ukrainian] Available from: https://www.dec.gov.ua/wp-content/uploads/2022/01/2022_151_ykpmd_giprozlvagitn.pdf 
17. Berbets A. Melatonin, pro-inflammatory cytokines and placental insufficiency. Current issues of pediatrics, obstetrics and gynecology. 2018; 2:24-6.
https://doi.org/10.11603/24116-4944.2018.2.8942
18. Berbets A. Placental insufficiency, melatonin, pro- and anti-inflammatory Cytokines. Current issues of pediatrics, obstetrics and gynecology. 2018; 1:37-40. [In Ukrainian] https://doi.org/10.11603/24116-4944.2018.1.7502
PMid:30099434
19. Genario R, Morello E, Bueno AA, Santos HO. The usefulness of melatonin in the field of obstetrics and gynecology. Pharmacol Res [Internet]. 2019; 147:104337.
https://doi.org/10.1016/j.phrs.2019.104337
PMid:31276773
20. Galano A, Reiter RJ. Melatonin and its metabolites vs oxidative stress: From individual actions to collective protection. J Pineal Res. 2018; 65(1):e12514.
https://doi.org/10.1111/jpi.12514
PMid:29888508
21. Hardeland R. Melatonin and the Programming of Stem Cells. International journal of molecular sciences, Int. J. Mol. Sci. 2022, 23(4), 1971;
https://doi.org/10.3390/ijms23041971
PMid:35216086 PMCid:PMC8879213
22. Luchetti F, Canonico B, Bartolini D, et al. Melatonin regulates mesenchymal stem cell differentiation: a review. J Pineal Res. 2014; 56(4):382-397.
https://doi.org/10.1111/jpi.12133
PMid:24650016
23. Oliveira MS, Barreto-Filho JB. Placental-derived stem cells: Culture, differentiation and challenges. World J Stem Cells. 2015;7(4):769-775.
https://doi.org/10.4252/wjsc.v7.i4.769
PMid:26029347 PMCid:PMC4444616

Savka R, Berbets. Sleep disorders and changes in melatonin concentrations in pregnant women with preeclampsia. Cell Organ Transpl. 2023; 11(2):130-135. Available from: https://doi.org/10.22494/cot.v11i2.158

 

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.